# EXECUTABLE EXPERIMENTAL DESIGN - INTEGRATION GUIDE

## Complete Workflows for Real-World Projects

This guide shows how to **chain executable workflows together** to design complete experiments from start to finish.

---

## PROJECT 1: Novel Antibiotic Discovery Pipeline

### Scenario
You want to discover new antibiotics to combat drug-resistant bacteria using computational genome mining and bioactivity validation.

### Integrated Workflow Sequence

#### PHASE 1: Prioritize Natural Products (Weeks 1-4)

**Use**: ML Bioactivity Prediction from BGC Workflow
- **ACTION 1**: Extract features from 147,000+ BGCs
  - OUTPUT: Feature vectors for all known clusters
- **ACTION 2**: Train ML model on known antibiotic BGCs
  - OUTPUT: Trained model with >0.80 ROC-AUC
- **ACTION 3**: Predict bioactivity for all BGCs
  - OUTPUT: **Ranked list of 1,000 predicted antibiotic-producing BGCs** ← FEEDS INTO PHASE 2

#### PHASE 2: Activate Top Candidates (Weeks 4-12)

**Use**: Silent BGC Activation Workflow (from available workflows)
- **INPUT**: Top 50 BGCs from Phase 1 that are silent (not expressed)
- **ACTION 1**: Design BGC expression constructs
  - OUTPUT: Cloning specifications for heterologous expression
- **ACTION 2**: Select optimal hosts and optimize
  - OUTPUT: Expression system ready for testing
- **ACTION 3**: Engineer regulatory elements
  - OUTPUT: **Optimized expression constructs** ← FEEDS INTO PHASE 3

#### PHASE 3: Validate Antibiotic Activity (Weeks 12-20)

**Use**: Custom Bioactivity Validation (simplified)
- **INPUT**: Expressed products from Phase 2
- Execute:
  1. Grow 20 candidate strains under optimized conditions
  2. Extract and purify metabolites
  3. Perform MIC (minimum inhibitory concentration) assays against:
     - *E. coli* (susceptible reference)
     - *Methicillin-resistant S. aureus* (MRSA)
     - *Carbapenem-resistant Enterobacteriaceae* (CRE)
  4. LC-MS characterization of active metabolites
  5. Structure elucidation for novel scaffolds
  - OUTPUT: **5-10 validated novel antibiotics with structures and activity data**

#### PHASE 4: Mechanism of Action Studies (Weeks 20-28)

**Use**: Design insights from Allosteric Effectors or Enzyme Engineering workflows
- **INPUT**: Top 3 novel antibiotics from Phase 3
- Execute:
  1. Identify molecular target using:
     - Comparative genomics of resistant mutants
     - Proteomics/transcriptomics of treated bacteria
  2. Validate target binding
  3. Design analogs to optimize potency/selectivity
  - OUTPUT: **Lead antibiotic candidates ready for preclinical development**

### Key Outputs Delivered
- ✓ 5-10 novel antibiotic structures
- ✓ Confirmed activity against resistant bacteria
- ✓ Mechanism of action understood
- ✓ Structure-activity relationships defined

### Timeline: 28 weeks (~7 months)

### Resource Budget (Typical)
- Computational: $2,000-5,000 (cloud computing, software)
- Experimental: $50,000-100,000 (reagents, equipment time)
- Personnel: 1 computational biologist (50%), 1-2 experimentalists (100%)

---

## PROJECT 2: Enzyme Engineering for Industrial Biocatalysis

### Scenario
You need to engineer an enzyme for sustainable production of a valuable chemical with improved activity and stability.

### Integrated Workflow Sequence

#### PHASE 1: Understand Conformational Dynamics (Weeks 1-8)

**Use**: AlphaFold2 Enzyme Conformational Flexibility Workflow
- **ACTION 1**: Generate conformational ensemble
  - INPUT: Enzyme sequence
  - OUTPUT: 50-100 diverse conformations
- **ACTION 2**: Reconstruct free energy landscape
  - OUTPUT: 3-5 distinct conformational states identified
- **ACTION 3**: Design mutations for better catalysis
  - OUTPUT: **Top 10 mutations predicted to improve activity** ← FEEDS INTO PHASE 2

#### PHASE 2: Characterize Fitness-Solubility Trade-offs (Weeks 8-23)

**Use**: Deep Mutational Scanning Enzyme Fitness Workflow
- **INPUT**: 
  - Target enzyme for improvement
  - Production substrate (chemical to be synthesized)
- **ACTION 1**: Design comprehensive mutation library
  - OUTPUT: 5,000+ variants in plasmid library
- **ACTION 2**: Perform dual selection (activity + solubility)
  - OUTPUT: Deep sequencing data showing fitness/solubility landscape
- **ACTION 3**: Build predictive models
  - OUTPUT: **Models predicting which mutations improve both activity and solubility** ← FEEDS INTO PHASE 3

#### PHASE 3: Design Optimized Variants (Weeks 23-29)

**Use**: Machine Learning Protein Design Workflow
- **INPUT**: Predictive models from Phase 2
- **ACTION 1**: Extract features predicting optimal variants
  - OUTPUT: Feature importance rankings
- **ACTION 2**: Design multi-mutation combinations
  - Execute ML optimization for best activity + solubility + expression
  - OUTPUT: 5-10 candidate multi-mutant designs
- **ACTION 3**: Validate predictions experimentally
  - Execute: Express and characterize each variant
  - Measure: kcat, KM, Tm, aggregation propensity
  - OUTPUT: **2-3 optimized variants with 3-5× improvement** ← FEEDS INTO PHASE 4

#### PHASE 4: Pilot Production and Optimization (Weeks 29-40)

**Use**: Enzyme Kinetics and Production Workflow
- **INPUT**: Best variant from Phase 3
- Execute:
  1. Scale-up expression (1-10 liter fermentation)
  2. Optimize production parameters (pH, temperature, time)
  3. Establish recycling/reuse protocol
  4. Economic analysis of production cost
  5. Regulatory pathway assessment
  - OUTPUT: **Production-ready enzyme for commercial scale-up**

### Key Outputs Delivered
- ✓ Enzyme improved 3-5× in activity
- ✓ Better solubility/stability for production
- ✓ Detailed kinetic characterization
- ✓ Production protocol established

### Timeline: 40 weeks (~10 months)

### Resource Budget (Typical)
- Computational: $5,000-10,000 (HPC resources, software)
- Experimental: $30,000-60,000 (reagents, protein expression, equipment)
- Personnel: 1 computational biologist (100%), 1-2 experimentalists (100%)

---

## PROJECT 3: Synthetic Biology Biosensor Development

### Scenario
Design a programmable biosensor to detect and respond to a specific metabolite for metabolic engineering or diagnostics.

### Integrated Workflow Sequence

#### PHASE 1: Biosensor Module Design (Weeks 1-8)

**Use**: Artificial Allosteric Protein Switches Workflow
- **ACTION 1**: Design ML-generated receptor domain
  - INPUT: Target ligand (metabolite)
  - OUTPUT: Computationally designed binding protein
- **ACTION 2**: Optimize linker and reporter pairing
  - OUTPUT: Biosensor construct specifications
- **ACTION 3**: Conformational analysis
  - OUTPUT: **Predicted biosensor architecture ready for testing**

#### PHASE 2: Regulatory Circuit Optimization (Weeks 8-16)

**Use**: Synthetic Regulatory Circuits Workflow
- **INPUT**: Biosensor from Phase 1
- **ACTION 1**: Model circuit dynamics
  - Execute: ODE modeling of sensor + promoter + reporter
  - OUTPUT: Optimized parameter set
- **ACTION 2**: Select genetic components
  - Execute: Design promoter/RBS combinations for tunable response
  - OUTPUT: **Optimized genetic components selected** ← FEEDS INTO PHASE 3

#### PHASE 3: Construct and Test (Weeks 16-28)

**Use**: Custom Biosensor Assembly
- **INPUT**: Genetic components from Phase 2
- Execute:
  1. Synthesize DNA sequences (IDT, gBlocks)
  2. Assemble using Golden Gate or Gibson
  3. Transform into *E. coli* or *Saccharomyces cerevisiae*
  4. Induce and measure response:
     - Without ligand (baseline)
     - With ligand (signal)
     - Dose-response curve
  5. Calculate:
     - Sensitivity (fold-change)
     - Dynamic range
     - Specificity (cross-talk with other metabolites)
  - OUTPUT: **Validated biosensor with characterized response** ← FEEDS INTO PHASE 4

#### PHASE 4: Application Testing (Weeks 28-36)

**Use**: Cellular Engineering Validation
- **INPUT**: Validated biosensor from Phase 3
- Execute:
  1. Integration into metabolic pathway feedback loop
  2. Test in production strain
  3. Measure:
     - Metabolite production improvement
     - Circuit stability over multiple generations
     - Toxicity to host
  4. Optimize for robustness
  - OUTPUT: **Production-ready biosensor for industrial implementation**

### Key Outputs Delivered
- ✓ Functional biosensor for target metabolite
- ✓ Characterized dose-response relationship
- ✓ Validated in cellular context
- ✓ Design rules for future biosensors

### Timeline: 36 weeks (~9 months)

### Resource Budget (Typical)
- Computational: $3,000-6,000
- Experimental: $20,000-40,000
- Personnel: 1 computational biologist (70%), 1-2 experimentalists (100%)

---

## WORKFLOW DECISION TREE

```
START: Choose Your Project Goal

│
├─→ DISCOVER NEW BIOACTIVE COMPOUNDS
│   ├─→ Use: ML Bioactivity BGC
│   ├─→ Then: Silent BGC Activation
│   ├─→ Timeline: 13-19 weeks
│   └─→ Best For: Natural product drug discovery
│
├─→ IMPROVE ENZYME ACTIVITY/STABILITY
│   ├─→ Use: AlphaFold2 Conformational + Deep Mutational Scanning
│   ├─→ Or: Machine Learning Protein Design
│   ├─→ Timeline: 15-30 weeks
│   └─→ Best For: Biocatalysis, protein therapeutics
│
├─→ DESIGN ALLOSTERIC DRUGS
│   ├─→ Use: Allosteric Effectors Drug Design
│   ├─→ Then: Computational Validation
│   ├─→ Timeline: 15-21 weeks
│   └─→ Best For: Precision medicine, reduced side effects
│
├─→ BUILD SYNTHETIC BIOLOGY CIRCUIT
│   ├─→ Use: Artificial Allosteric Switches
│   ├─→ Then: Synthetic Regulatory Circuits
│   ├─→ Timeline: 16-28 weeks
│   └─→ Best For: Biosensors, metabolic engineering
│
└─→ UNDERSTAND PROTEIN EVOLUTION
    ├─→ Use: Protein Evolution Adaptive Landscapes
    ├─→ Then: Machine Learning Protein Design
    ├─→ Timeline: 12-20 weeks
    └─→ Best For: Directed evolution guidance, fundamental biology
```

---

## Integration Checklist

For each integrated project:

- [ ] **Workflow 1 outputs documented** (data files, quality metrics)
- [ ] **Compatibility checked** between successive workflows
- [ ] **Resource availability confirmed** (equipment, personnel, budget)
- [ ] **Decision points identified** (where to pivot if needed)
- [ ] **Failure modes considered** (what if success rate is 10% instead of 30%?)
- [ ] **Timeline buffer added** (add 25-50% to estimates)
- [ ] **Milestones scheduled** (weekly/monthly check-ins)
- [ ] **Data backup plan** (redundancy for critical results)
- [ ] **Publication strategy** (what will be submitted where?)
- [ ] **IP considerations** (patents, licensing of computational tools)

---

## Real Timeline Example: Antibiotic Discovery

**OPTIMISTIC SCENARIO** (everything works first try):
```
Week 1-4:   ML training and ranking (Phase 1)
Week 4-12:  BGC expression optimization (Phase 2)
Week 12-16: Bioactivity validation (Phase 3a - screening)
Week 16-20: Structure elucidation (Phase 3b - NMR/MS)
Week 20-24: Mechanism studies (Phase 4)
TOTAL:      24 weeks, 3 publications
```

**REALISTIC SCENARIO** (normal troubleshooting):
```
Week 1-4:   ML training, need to refine model (Phase 1)
Week 4-6:   Model refinement and revalidation
Week 6-14:  BGC expression, first 3 fail, redesign (Phase 2)
Week 14-18: Bioactivity validation (Phase 3a)
Week 18-22: Limited structure info from first compounds
Week 22-28: Mechanism studies, test 2 leads
Week 28-32: Analog design and testing
TOTAL:      32 weeks, 2-3 publications
```

**CHALLENGING SCENARIO** (major issues):
```
Week 1-6:   ML model underperforms, get more training data (Phase 1)
Week 6-12:  Model retraining with better features
Week 12-18: Most expressed BGCs are known compounds (Phase 2)
Week 18-24: Expand to more BGCs, more screening (Phase 3a)
Week 24-32: Poor activity or toxicity issues (Phase 3b)
Week 32-40: Troubleshoot, consider alternative targets
TOTAL:      40+ weeks, 1-2 publications
```

---

## Success Factors

Projects succeed when you:

1. **Know your stopping point** - Define what "success" looks like upfront
2. **Build flexibility into timelines** - Expect delays at each phase
3. **Communicate across teams** - Computational and experimental must align
4. **Document everything** - Future reproducibility depends on it
5. **Iterate intelligently** - Use decision points to pivot when needed
6. **Validate assumptions** - Test computational predictions experimentally
7. **Share failures** - Learn from what doesn't work

---

*This guide is a template - adapt to your specific system, resources, and timeline.*
